Found 6 resultsAuthor [ Title] Type Year
Filters: First Letter Of Title is P and Author is Gilmour, J [Clear All Filters]
Phase 1 Safety and Immunogenicity Evaluation of ADVAX a Multigenic, DNA-Based Clade C/B’ HIV-1 Candidate Vaccine. PLoS ONE, 5, e8617. presented at the 01/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20111582. (2010).
A Phase 2 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Vaccine Based on Adeno-Associated Virus. AIDS Res Hum Retroviruses, 26, 933-942. presented at the 08/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20666584. (2010).
Phase 2A Dose and Route Study of a DNA Prime MVA Boost Vaccine Candidate. In AIDS Vaccine 2005 International Conference. presented at the 06/09/2005, Montreal, Quebec, Canada.. (2005).
A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults. PLoS One, 7, e41936. presented at the 08/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22870265. (2012).
A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults. PLoS One, 10, e0125954. presented at the 05/2015. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25961283. (2015).